Current Medicinal Chemistry

MicroRNAs and Lung Cancer: New Oncogenes and Tumor Suppressors, New Prognostic Factors and Potential Therapeutic Targets
pp. 1047-1061(15)
Authors: Ortholan, Cecile; Puissegur, Marie-Pierre; Ilie, Marius; Barbry, Pascal; Mari, Bernard; Hofman, Paul

Chalcones in Cancer: Understanding their Role in Terms of QSAR
pp. 1062-1081(20)
Authors: Katsori, A.-M.; Hadjipavlou-Litina, D.

Beta-Adrenergic Antagonists: Indications and Potential Immunomodulatory Side Effects in the Critically Ill
pp. 1082-1090(9)
Authors: Oberbeck, Reiner; Kobbe, Philipp

Macrophage Migration Inhibitory Factor (MIF) Tautomerase Inhibitors as Potential Novel Anti-Inflammatory Agents: Current Developments
pp. 1091-1114(24)
Authors: Garai, Janos; Lorand, Tamas

Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
pp. 1115-1121(7)
Authors: Gentile, I.; Viola, C.; Borgia, F.; Castaldo, G.; Borgia, G.

Cyclodepsipeptides - Potential Drugs and Lead Compounds in the Drug Development Process
pp. 1122-1137(16)
Authors: Lemmens-Gruber, R.; Kamyar, M. R.; Dornetshuber, R.

Role of Phytochemicals in the Prevention of Menopausal Bone Loss: Evidence from In Vitro and In Vivo, Human Interventional and Pharmacokinetic Studies
pp. 1138-1157(20)
Authors: Sharan, Kunal; Siddiqui, Jawed A.; Swarnkar, Gaurav; Maurya, Rakesh; Chattopadhyay, Naibedya

Identification of Canonical Transient Receptor Potential (TRPC) Channel Proteins in Native Vascular Smooth Muscle Cells
pp. 1158-1165(8)
Authors: Albert, Anthony P.; Saleh, Sohag N.; Large, William A.

Acyclonucleosides, Modified Seco-Nucleosides, and Salicyl- or Catechol- Derived Acyclic 5-Fluorouracil O,N-Acetals: Antiproliferative Activities, Cellular Differentiation and Apoptosis
pp. 1166-1183(18)
Authors: Marchal, Juan A.; Nunez, Maria C.; Aranega, Antonia; Gallo, Miguel A.; Espinosa, Antonio; Campos, Joaquin M.